These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2306476)

  • 1. Inactivation of dopamine beta-hydroxylase by p-cresol: evidence for a second, minor site of covalent modification at tyrosine 357.
    Southan C; DeWolf WE; Kruse LI
    Biochim Biophys Acta; 1990 Feb; 1037(2):256-8. PubMed ID: 2306476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of dopamine beta-hydroxylase by p-cresol: isolation and characterization of covalently modified active site peptides.
    DeWolf WE; Carr SA; Varrichio A; Goodhart PJ; Mentzer MA; Roberts GD; Southan C; Dolle RE; Kruse LI
    Biochemistry; 1988 Dec; 27(26):9093-101. PubMed ID: 3242615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols.
    Goodhart PJ; DeWolf WE; Kruse LI
    Biochemistry; 1987 May; 26(9):2576-83. PubMed ID: 3607034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of dopamine beta-hydroxylase by beta-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide.
    DeWolf WE; Chambers PA; Southan C; Saunders D; Kruse LI
    Biochemistry; 1989 May; 28(9):3833-42. PubMed ID: 2751998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The copper sites of dopamine beta-hydroxylase: an X-ray absorption spectroscopic study.
    Scott RA; Sullivan RJ; DeWolf WE; Dolle RE; Kruse LI
    Biochemistry; 1988 Jul; 27(15):5411-7. PubMed ID: 3179263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active site labeling of dopamine beta-hydroxylase by two mechanism-based inhibitors: 6-hydroxybenzofuran and phenylhydrazine.
    Farrington GK; Kumar A; Villafranca JJ
    J Biol Chem; 1990 Jan; 265(2):1036-40. PubMed ID: 2295598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine dopamine beta-hydroxylase, primary structure determined by cDNA cloning and amino acid sequencing.
    Wang N; Southan C; DeWolf WE; Wells TN; Kruse LI; Leatherbarrow RJ
    Biochemistry; 1990 Jul; 29(27):6466-74. PubMed ID: 2207088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase.
    Kruse LI; DeWolf WE; Chambers PA; Goodhart PJ
    Biochemistry; 1986 Nov; 25(23):7271-8. PubMed ID: 3801416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes for catecholamine biosynthesis: cloning by expression and identification of the cDNA for rat dopamine beta-hydroxylase.
    O'Malley KL; Mauron A; Raese J; Barchas JD; Kedes L
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2161-5. PubMed ID: 6572968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of dopamine beta-hydroxylase by bidentate chelating agents.
    Townes S; Titone C; Rosenberg RC
    Biochim Biophys Acta; 1990 Feb; 1037(2):240-7. PubMed ID: 2306475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inhibition of dopamine beta-monooxygenase by quinol and phenol derivatives, as determined by solvent and substrate deuterium isotope effects.
    Kim SC; Klinman JP
    Biochemistry; 1991 Aug; 30(33):8138-44. PubMed ID: 1868089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray absorption spectroscopic study of the active copper sites in dopamine beta-hydroxylase.
    Blumberg WE; Desai PR; Powers L; Freedman JH; Villafranca JJ
    J Biol Chem; 1989 Apr; 264(11):6029-32. PubMed ID: 2703478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The primary structure of human dopamine-beta-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme.
    Lamouroux A; Vigny A; Faucon Biguet N; Darmon MC; Franck R; Henry JP; Mallet J
    EMBO J; 1987 Dec; 6(13):3931-7. PubMed ID: 3443096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral studies of bovine dopamine beta-hydroxylase. Absence of covalently bound pyrroloquinoline quinone.
    Robertson JG; Kumar A; Mancewicz JA; Villafranca JJ
    J Biol Chem; 1989 Nov; 264(33):19916-21. PubMed ID: 2555337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternate substrates of dopamine beta-hydroxylase. III. Stoichiometry of the inactivation reaction with benzyl cyanides and spectroscopic investigations.
    Colombo G; Rajashekhar B; Ash DE; Villafranca JJ
    J Biol Chem; 1984 Feb; 259(3):1607-15. PubMed ID: 6319404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Picolinic acids as inhibitors of dopamine beta-monooxygenase: QSAR and putative binding site.
    Dove S
    Arch Pharm (Weinheim); 2004 Dec; 337(12):645-53. PubMed ID: 15597398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence similarity between dopamine beta-hydroxylase and peptide alpha-amidating enzyme: evidence for a conserved catalytic domain.
    Southan C; Kruse LI
    FEBS Lett; 1989 Sep; 255(1):116-20. PubMed ID: 2792366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of dopamine beta-hydroxylase.
    Sams CF; Matthews KS
    Biochim Biophys Acta; 1984 May; 787(1):61-70. PubMed ID: 6722174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subunit characterization and primary structure of bovine adrenal medullary dopamine beta-hydroxylase.
    Wong DL; Bildstein CL
    Neuropsychopharmacology; 1990 Apr; 3(2):115-28. PubMed ID: 2317264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.